[Dermatological news from America. I].
D000152:Acne Vulgaris / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001327:Autoimmune Diseases; D001768:Blister; D002648:Child; D002675:Child, Preschool; D003877:Dermatitis, Contact / Q000209:etiology; D004342:Drug Hypersensitivity; D005260:Female; D006562:Herpes Zoster / Q000175:diagnosis; D006801:Humans; D006968:Hypersensitivity, Delayed; D007642:Keratosis / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000276:immunology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009062:Mouth Neoplasms; D009506:Nevus; D010392:Pemphigus / Q000188:drug therapy / Q000276:immunology; D010698:Phobic Disorders; D011241:Prednisone / Q000627:therapeutic use; D011565:Psoriasis / Q000139:chemically induced; D012871:Skin Diseases; D012874:Skin Diseases, Infectious; D012878:Skin Neoplasms; D013471:Sunburn / Q000517:prevention & control; D014382:Tuberculosis, Cutaneous; D014481:United States; D014777:Virus Diseases; D014973:Xanthomatosis / Q000473:pathology
D000900:Anti-Bacterial Agents; D011241:Prednisone; D008727:Methotrexate
Neues aus der amerikanischen Dermatologie.